Followers | 271 |
Posts | 54208 |
Boards Moderated | 11 |
Alias Born | 08/29/2007 |
![](https://investorshub.advfn.com/uicon/108458.png?cb=1482855649)
Wednesday, April 24, 2024 2:48:41 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent APLM News
- Biotech Sees Massive Buying Pressure Following Phase 2 Preliminary Data • AllPennyStocks.com • 08/13/2024 02:50:00 PM
- Apollomics Announces Vebreltinib Data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 06/04/2024 12:00:00 PM
- Apollomics Announces Presentation at the 2024 BIO International Convention • GlobeNewswire Inc. • 05/29/2024 12:00:00 PM
- Apollomics Announces Private Placement Financing and Addition to Board of Directors • GlobeNewswire Inc. • 05/08/2024 08:05:00 PM
- Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene • GlobeNewswire Inc. • 04/25/2024 12:30:00 PM
- Apollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 04/10/2024 11:00:00 AM
- Apollomics Announces Poster Presentations of Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 04/02/2024 12:00:00 PM
- Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/28/2024 11:00:00 AM
- Apollomics to Announce Full Year 2023 Financial Results and Host Conference Call on March 28, 2024 • GlobeNewswire Inc. • 03/26/2024 12:00:00 PM
- Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer • GlobeNewswire Inc. • 03/04/2024 12:00:00 PM
- Apollomics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/07/2024 12:00:00 PM
- Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency • GlobeNewswire Inc. • 01/19/2024 09:15:00 PM
- Apollomics to Participate in a Fireside Chat at the B. Riley Securities’ 2024 Virtual Oncology Conference • GlobeNewswire Inc. • 01/17/2024 09:30:00 PM
- Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia • GlobeNewswire Inc. • 01/03/2024 12:00:00 PM
- Apollomics to Present at the 2024 Biotech Showcase • GlobeNewswire Inc. • 01/02/2024 09:30:23 PM
- Apollomics Presents Interim Data from Two Ongoing Phase 2 Clinical Trials with Vebreltinib in NSCLC Patients with MetExon14 Skipping Mutation • GlobeNewswire Inc. • 12/04/2023 12:00:00 PM
- Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference • GlobeNewswire Inc. • 11/29/2023 12:30:00 PM
- Apollomics Announces Presentation of Vebreltinib Data at the 2023 IASLC North America Conference on Lung Cancer (NACLC) • GlobeNewswire Inc. • 11/28/2023 12:00:40 PM
- Apollomics Announces the First Approval of Vebreltinib for MET Exon 14 Skip Non-Small Cell Lung Cancer • GlobeNewswire Inc. • 11/16/2023 01:30:00 PM
- Apollomics Announces Two New Cohorts in Global Phase 2 SPARTA Study of Vebreltinib in Non-Small Cell Lung Cancer and Other Solid Tumors with MET Dysregulation • GlobeNewswire Inc. • 10/31/2023 12:30:06 PM
- Apollomics Announces Report of Activity of Vebreltinib in Glioblastoma Multiforme (GBM) with PTPRZ-MET Fusion • GlobeNewswire Inc. • 10/26/2023 12:50:02 PM
- Apollomics Announces Efficacy of Vebreltinib in NSCLC Patients with MetEx14 Skipping Mutation Achieving an Overall Response Rate (ORR) of 75% • GlobeNewswire Inc. • 10/23/2023 12:30:21 PM
- Apollomics Announces Presentations of Vebreltinib Data at ESMO 2023 • GlobeNewswire Inc. • 10/16/2023 10:55:05 PM
- Apollomics Reports First Half 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 09/28/2023 08:17:57 PM
- Apollomics to Present at the H.C. Wainwright 25th Annual Global Investment Conference • GlobeNewswire Inc. • 09/06/2023 11:00:00 AM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM